Abstract
The concept, molecular self-assembly, especially considering molecule-molecule interaction as an informationprocessing phenomenon, have a profoundly novel effect on thoughts and efforts related to Medicine and Pharmacology. This new style of thinking is still too novice to be used solely and independently for explanation of disease mechanisms and appropriate treatment strategies. However it calls for a range of new researches based on new predictions about disease mechanisms (especially Autoimmune diseases, Endocrinopathies, and Neoplasms) and relevant treatment strategies (superstructural drugs).
Keywords: Self-assembly, Non-covalent interaction, Cell membrane, Autoimmunity, Anti-viral drugs, Sickle cell anemia
Current Pharmaceutical Analysis
Title: The Impact of Self-Assembly in Medicine and Pharmacology
Volume: 2 Issue: 1
Author(s): Mahnaz Derakhshan, Hamid R. Ansarian, Makoto Takafuji, Toshihiko Sakurai and Hirotaka Ihara
Affiliation:
Keywords: Self-assembly, Non-covalent interaction, Cell membrane, Autoimmunity, Anti-viral drugs, Sickle cell anemia
Abstract: The concept, molecular self-assembly, especially considering molecule-molecule interaction as an informationprocessing phenomenon, have a profoundly novel effect on thoughts and efforts related to Medicine and Pharmacology. This new style of thinking is still too novice to be used solely and independently for explanation of disease mechanisms and appropriate treatment strategies. However it calls for a range of new researches based on new predictions about disease mechanisms (especially Autoimmune diseases, Endocrinopathies, and Neoplasms) and relevant treatment strategies (superstructural drugs).
Export Options
About this article
Cite this article as:
Derakhshan Mahnaz, Ansarian R. Hamid, Takafuji Makoto, Sakurai Toshihiko and Ihara Hirotaka, The Impact of Self-Assembly in Medicine and Pharmacology, Current Pharmaceutical Analysis 2006; 2 (1) . https://dx.doi.org/10.2174/157341206775473990
DOI https://dx.doi.org/10.2174/157341206775473990 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Current Pharmaceutical Design Regulatory T Cell Therapy for Type I Diabetes Targeting on β Cell Associated Autoantigens
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Manipulating Thymic Apoptosis for Future Therapy of Autoimmune Diseases
Current Pharmaceutical Design Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
Current Pharmaceutical Design Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
Cardiovascular & Hematological Disorders-Drug Targets Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases
Current Pharmaceutical Analysis The Emergence of Multiplexed Technologies as Diagnostic Platforms in Systemic Autoimmune Diseases
Current Medicinal Chemistry Preface [Hot Topic: Transcription Factors as Targets of Novel Therapeutic Approaches of Autoimmune Diseases (Executive Editor: Gunther Ne)]
Current Pharmaceutical Design Emerging Role of Regulatory T Cells in Gene Transfer
Current Gene Therapy CCL17/Thymus and Activation-Related Chemokine: A biomarker for Churg-Strauss Syndrome?
Current Biomarkers (Discontinued) Influence of Genetic Polymorphisms on Mycophenolic Acid Pharmacokinetics and Patient Outcomes in Renal Transplantation
Current Drug Metabolism CD26 / Dipeptidyl Peptidase IV: A Regulator of Immune Function and a Potential Molecular Target for Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Study of HLA Class II and Autoimmune Diabetes
Current Molecular Medicine Effects of Secondhand Smoke on Thyroid Function
Inflammation & Allergy - Drug Targets (Discontinued) Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmunity in Type 1 Diabetes
Current Stem Cell Research & Therapy Use of Mesenchymal Stem Cells in Crohn's Disease and Perianal Fistulas: A Narrative Review
Current Stem Cell Research & Therapy New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines
Current Drug Targets - Immune, Endocrine & Metabolic Disorders